1、 程文俊,王俊文,任义军,等.利伐沙班与低分子量肝素在初次全髋关节置换术后深静脉血栓形成防治中的比较研究[J]. 中华创伤骨科杂志, 2012,14(6): 480-483. 程文俊,王俊文,任义军,等.利伐沙班与低分子量肝素在初次全髋关节置换术后深静脉血栓形成防治中的比较研究[J]. 中华创伤骨科杂志, 2012,14(6): 480-483.
2、 Gomez-outes SA, Terleira-fernandez AI, SUAREZ-GEA M L, et al. Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons [J]. BMJ, 2012(344):e3675. Gomez-outes SA, Terleira-fernandez AI, SUAREZ-GEA M L, et al. Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons [J]. BMJ, 2012(344):e3675.
3、 Beyer-westendorf J, Lutzner J, Donath L, et al. Efficacy and safety of rivaroxaban or fondaparinux thromboprophylaxis in major orthopedic surgery: findings from the ORTHO-TEP registry [J]. J Thromb Haemost, 2012, 10(10): 2045-2052. Beyer-westendorf J, Lutzner J, Donath L, et al. Efficacy and safety of rivaroxaban or fondaparinux thromboprophylaxis in major orthopedic surgery: findings from the ORTHO-TEP registry [J]. J Thromb Haemost, 2012, 10(10): 2045-2052.
4、 Russell RD, Huo MH. Apixaban and rivaroxaban decrease deep venous thrombosis but not other complications after total hip and total knee arthroplasty [J]. J Arthroplasty, 2013, 28(9): 1477-1481. Russell RD, Huo MH. Apixaban and rivaroxaban decrease deep venous thrombosis but not other complications after total hip and total knee arthroplasty [J]. J Arthroplasty, 2013, 28(9): 1477-1481.
5、 李军,崔晓丙,王健,等. 利伐沙班预防髋膝关节置换术后静脉血栓疗效的Meta分析[J]. 中国全科医学,2011(27):3127-3130. 李军,崔晓丙,王健,等. 利伐沙班预防髋膝关节置换术后静脉血栓疗效的Meta分析[J]. 中国全科医学,2011(27):3127-3130.
6、 Jameson SS, Rymaszewska M, HUI AC, et al. Wound complications following rivaroxaban administration: a multicenter comparison with low-molecular-weight heparins for thromboprophylaxis in lower limb arthroplasty [J]. J Bone Joint Surg Am, 2012, 94(17): 1554-1558. Jameson SS, Rymaszewska M, HUI AC, et al. Wound complications following rivaroxaban administration: a multicenter comparison with low-molecular-weight heparins for thromboprophylaxis in lower limb arthroplasty [J]. J Bone Joint Surg Am, 2012, 94(17): 1554-1558.
7、 Falck-ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [J]. Chest, 2012, 141(2 Suppl): e278S-325S. Falck-ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [J]. Chest, 2012, 141(2 Suppl): e278S-325S.
8、 Dixon T, Shaw M, Ebrahim S, et al. Trends in hip and knee joint replacement: socioeconomic inequalities and projections of need [J]. Ann Rheum Dis, 2004, 63(7): 825-830. Dixon T, Shaw M, Ebrahim S, et al. Trends in hip and knee joint replacement: socioeconomic inequalities and projections of need [J]. Ann Rheum Dis, 2004, 63(7): 825-830.
9、 Van Manen,Nace J,Mont MA.Management of Primary Knee Osteoarthritis and Indications for Total Knee Arthroplasty for General Practitioners[J].J Am Osteopath Assoc,2012(11):709-715. Van Manen,Nace J,Mont MA.Management of Primary Knee Osteoarthritis and Indications for Total Knee Arthroplasty for General Practitioners[J].J Am Osteopath Assoc,2012(11):709-715.
10、 Corti MC, Rigon C. Epidemiology of osteoarthritis: prevalence, risk factors and functional impact [J]. Aging Clin Exp Res, 2003, 15(5): 359-363. Corti MC, Rigon C. Epidemiology of osteoarthritis: prevalence, risk factors and functional impact [J]. Aging Clin Exp Res, 2003, 15(5): 359-363.
11、 CarR AJ, Robertsson O, Graves S, et al. Knee replacement [J]. Lancet, 2012, 379(9823): 1331-1340. CarR AJ, Robertsson O, Graves S, et al. Knee replacement [J]. Lancet, 2012, 379(9823): 1331-1340.
12、 Januel JM, Chen G, Rrffieux C, et al. Symptomatic in-hospital deep vein thrombosis and pulmonary embolism following hip and knee arthroplasty among patients receiving recommended prophylaxis: a systematic review [J]. Jama, 2012, 307(3): 294-303. Januel JM, Chen G, Rrffieux C, et al. Symptomatic in-hospital deep vein thrombosis and pulmonary embolism following hip and knee arthroplasty among patients receiving recommended prophylaxis: a systematic review [J]. Jama, 2012, 307(3): 294-303.
